Harvard Innovation Labs Ventures in Biotech and Therapeutics
- Karan Bhatia

- 18 hours ago
- 2 min read

(This round-up is for informational purposes only and in alphabetical order)
1) Melia Diagnostics: Melia Diagnostics researches and develops novel point-of-care diagnostic solutions for dogs and cats. Know More At: meliadiagnostics.com
2) Modulate Bio: Led by Andrew Thomson, MBA, Dario Doller, PhD, and
Kevin Hodgetts, PhD, Modulate Bio is developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety. Know More At: modulatebio.com
3) Momentum Therapeutics: Led by Antonio Henriques, Sebastían Bernales, Felipe Court, and the team, Momentum Therapeutics is developing therapies that restore cellular resilience by targeting the fundamental mechanisms of aging and degeneration. Know More At: momentumtx.bio
4) Overture Therapeutics: Led by PJ Krohl and Russell Beckerman, Overture Therapeutics is creating better, healthier weight-loss intervention therapies for treating obesity and its co-morbidities by targeting emerging biological pathways. Know More At: overture-tx.com
5) PathCision Medicine, Inc: Led by Shana Wang, David Lee, M.D., Ph.D, and the team, PathCision Medicine is developing tissue-informed precision therapeutics with superior delivery and efficacy for cancer and other complex diseases. Know More At: pathcisionmedicine.com
6) Promakhos Therapeutics: Led by Katerina Chatzi, Ph.D, Jasper E. Neggers, Ph.D, and the team, Promakhos Therapeutics is developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders. Know More At: promakhos.com
7) Regatta Bio: Founded by Dr. Leslie Kean, Regatta Bio is developing cellular therapies to restore immune tolerance and prevent immune system-related diseases. Know More At: regatta.bio
8) Revision Bio: Led by Shantanu Kumar, PhD, Cody Tranbarger, and the team, Revision Bio is creating next-generation precision genome editing technologies. Know More At: revision.bio
9) Stratagen Bio: Gregory Ekchian, PhD, Michael Cima, PhD, and the team, Stratagen Bio is transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment. Know More At: stratagenbio.com


